This is a routine filing with no immediate trading implications. Monitor for the actual meeting date and any subsequent filings that might contain more substantive information.
KRYS drugs
KRYS drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 6 $261.80entry
- T+1 · 7mo ago +0.84%α +0.77% · $263.99
- T+5 · 7mo ago +2.14%α −1.99% · $267.41
- T+20 · 7mo ago +9.61%α +0.62% · $286.95
- T+60 · 5mo ago +41.93%α +28.46% · $371.58
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Krystal Biotech filed a definitive proxy statement (DEFA14A) for an upcoming shareholder meeting. The filing is routine and contains standard information about voting procedures and meeting logistics. No material changes or activist campaigns are indicated.
Key Facts
- Filing is a definitive proxy statement (DEFA14A) for Krystal Biotech, Inc. (KRYS)
- Document is routine and contains standard voting information
- No indication of activist campaigns, mergers, or significant corporate actions
- Filing appears to be for standard annual meeting procedures
Financial Impact
No immediate financial impact
Risk Factors
- None identified from this filing
- Potential for future activist activity not indicated in this document
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001711279-26-000037 |
| Document: 0001711279-26-000037-index-headers.html | 0001711279-26-000037 |
| Document: 0001711279-26-000037-index.html | 0001711279-26-000037 |
| Document: 0001711279-26-000037.txt | 0001711279-26-000037 |
Track record
18 reports on KRYS
3 of 4 bullish or bearish reports moved the stock their way by T+20. Best: +26.60% at T+60 after the May 4, 2026 report. 6 of 7 went positive at some point.
Filters
- Nov 2, 202614d ago 8-K Bullish 6/10 No price data
- Nov 2, 202614d ago Press Release Bullish 6/10 Entry $295.90 Now $297.90 +0.68% settles Dec 1
- Oct 30, 202617d ago SC 13G/A Bearish 5/10 Entry $332.29 Now $297.90 +10.35% settles Nov 30
- Oct 27, 202620d ago Institutional Cluster Bullish 4/10 Entry $321.42 Now $297.90 −7.32% settles Nov 25
- Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $321.42 Now $297.90 −7.32% settles Nov 25
- Oct 22, 202625d ago Press Release Neutral 1/10 Entry $320.13 Now $297.90 −6.94% settles Nov 19
- Oct 21, 202626d ago Institutional Cluster Neutral 3/10 Entry $320.13 Now $297.90 −6.94% settles Nov 19
- Oct 15, 20264w ago 8-K Bullish 6/10 Entry $330.00 to $305.68 Now $297.90 −9.73% ▼ −7.37% −5.47% vs SPY
- Sep 4, 202610w ago Insider Cluster Bearish 5/10 Entry $351.26 to $326.81 Now $297.90 +15.19% ▲ +6.96% +8.67% vs SPY
- Aug 14, 202613w ago 144 Neutral 2/10 Entry $335.73 to $336.68 Now $297.90 −11.27% ▲ +0.28% +2.26% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers